Celladon Corporation and SIRO Clinpharm (India) Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference"
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MUMBAI, May 10, 2013 /PRNewswire/ --
Analysis of Recurrent Heart Failure Hospitalizations in Presence of Informative Censoring - Application of Joint Frailty Model
Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that it will present analysis methods for the MYDICAR development program at an upcoming conference.
Help employers find you! Check out all the jobs and post your resume.
MUMBAI, May 10, 2013 /PRNewswire/ --
Analysis of Recurrent Heart Failure Hospitalizations in Presence of Informative Censoring - Application of Joint Frailty Model
Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that it will present analysis methods for the MYDICAR development program at an upcoming conference.
Help employers find you! Check out all the jobs and post your resume.